Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 μg ethinylestradiol and 150 μg levonorgestrel: a randomized trial
Author(s) -
K Oddsson,
B. Leifels-Fischer,
Dominique Wiel-Masson,
Nilson Roberto de Melo,
Chiara Benedetto,
Carole Verhoeven,
T.O.M. Dieben
Publication year - 2004
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deh604
Subject(s) - vaginal ring , medicine , levonorgestrel , ethinylestradiol , gynecology , population , desogestrel , etonogestrel , randomized controlled trial , gestodene , family planning , surgery , research methodology , environmental health
This trial was conducted to compare cycle control with vaginal ring a combined contraceptive vaginal ring, and a combined oral contraceptive (COC) delivering 30 mug ethinylestradiol (EE) and 150 mug levonorgestrel.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom